A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as effective treatments that are in high demand. But should they be available to anyone who wants them or only when medically indicated?    Those who believe they should be broadly available say they can increase self-esteem and are an important tool for those unable to lose weight through lifestyle changes alone. They also say they may reduce the risks of diabetes, heart disease, and joint issues…